Advertisement

Boston Scientific Corp. (NYSE: BSX) launched two new products this week, a pre-dilatation balloon catheter designed for difficult lesions in coronary arteries in Europe, and a brain stimulation device for the treatment of Parkinson’s disease in the U.S.

Advertisement
Advertisement